Ascletis Pharma Webinar Highlights Innovative Obesity Treatments

Author: Hannah Lewis Updated: 03-20-2025 07:15 AM

Ascletis Pharma to Host Informative Obesity Portfolio Webinar

Ascletis Pharma Inc. (HKEX:1672, "Ascletis") is excited to announce its upcoming Obesity Portfolio Webinar scheduled for April 2, 2025. The webinar is set to take place from 9:00 a.m. to 10:30 a.m. Eastern Time. This virtual event aims to provide in-depth insights into Ascletis’ innovative approaches to obesity treatment.

Details of the Webinar

The webinar will showcase significant developments concerning Ascletis’ obesity portfolio. Participants can expect detailed discussions on ASC30, an exciting clinical stage GLP-1R biased small molecule agonist. This molecule is being developed for both daily oral tablet and monthly subcutaneous injection administration, presenting promising pathways for treatment.

Presenters and Q&A Session

Dr. Jinzi Jason Wu, the Founder, Chairman, and CEO of Ascletis, along with John Gargiulo, the Chief Business Officer, will lead the presentation. Following the main presentation, there will be a Q&A session where attendees can engage directly with the presenters.

How to Register for the Webinar

Interested individuals can register for the event to ensure their participation. A simple registration process will grant access to the virtual presentation. If you wish to attend this informative session, please secure your spot by registering.

Accessing the Replay

For those unable to attend the webinar live, an archived replay of the session will be made available for 30 days post-event. This will allow attendees to revisit the insightful discussions and expert presentations at their convenience.

About Ascletis Pharma Inc.

Ascletis is a pioneering biotech company listed on the Hong Kong Stock Exchange (1672.HK). The organization is driven by a commitment to research and development, concentrated on addressing significant unmet medical needs in two primary areas: metabolic diseases and viral diseases. With a robust drug development pipeline, Ascletis is dedicated to advancing various clinical-stage candidates aimed at improving patient outcomes globally.

Company Contact Information

For further inquiries related to the webinar or about Ascletis, individuals are encouraged to reach out to the company’s PR and IR teams. They are available to answer questions and provide additional information regarding the products, research efforts, and participation in upcoming events.

Frequently Asked Questions

What is the significance of the upcoming webinar?

The webinar addresses Ascletis’ innovative solutions for obesity, showcasing important developments and clinical data.

Who will present in the webinar?

Dr. Jinzi Jason Wu and John Gargiulo will lead the presentation, followed by a Q&A session.

How can I register for the event?

Registration details will be provided to allow you to secure your attendance at the event.

Will there be a replay available for the webinar?

Yes, an archived replay will be accessible for 30 days following the event.

What areas does Ascletis focus on in terms of R&D?

Ascletis is focused on metabolic diseases and viral diseases, working to develop innovative drug candidates in these fields.

About The Author

Hi there, I'm Hannah Lewis, a writer and financial specialist of 36 years old committed to making money understandable and approachable to everyone. Years of working in the field have given me a thorough grasp of market trends, investment techniques, and economic fundamentals. My objective is to enable people, by means of understandable, useful guidance, to take charge of their financial destiny.

I have written many articles for financial blogs over my career that simplify difficult financial ideas into understandable insights. Being financially literate is a critical ability, and I am passionate about enabling people to confidently manage their financial lives. Regardless of your level of experience, my work will help you at every stage of the investment process. I appreciate being allowed to share in your success and financial expansion.

Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.